Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Long-Term Debt Repayments (2016 - 2025)

Dare Bioscience (DARE) has disclosed Long-Term Debt Repayments for 8 consecutive years, with $121680.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Long-Term Debt Repayments fell 2.51% year-over-year to $121680.0, compared with a TTM value of $558529.0 through Sep 2025, down 5.72%, and an annual FY2024 reading of $579223.0, up 73.43% over the prior year.
  • Long-Term Debt Repayments was $121680.0 for Q3 2025 at Dare Bioscience, up from $62407.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $200391.0 in Q4 2023 and bottomed at $62407.0 in Q2 2025.
  • Average Long-Term Debt Repayments over 3 years is $142724.0, with a median of $133594.0 recorded in 2023.
  • The sharpest move saw Long-Term Debt Repayments fell 6.57% in 2024, then dropped 2.51% in 2025.
  • Year by year, Long-Term Debt Repayments stood at $200391.0 in 2023, then fell by 6.57% to $187221.0 in 2024, then crashed by 35.01% to $121680.0 in 2025.
  • Business Quant data shows Long-Term Debt Repayments for DARE at $121680.0 in Q3 2025, $62407.0 in Q2 2025, and $187221.0 in Q1 2025.